Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450144) titled 'A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: The University of Hong Kong
Condition:
Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic Alcohol-Related Liver Disease
Intervention:
Behavioral: LLM-based chatbot
Behavioral: Telephone counseling
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 18, ...